FDA Inspection 1112160 — BCN Peptides SA

BCN Peptides SA — FEI 3008205509

The FDA completed an inspection of BCN Peptides SA on March 15, 2019 in Sant Quinti De Mediona. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 15, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sant Quinti De Mediona (Spain)

Additional Details

Mutual Recognition Agreement (MRA)